Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in the Follow up of Patients With Colorectal Carcinoma.

The goal of this observational study is to learn about the diagnostic and prognostic value of 18f fdg pet ct in follow up of colorectal cancer patients The main question it aims to answer is:

Does pet ct have a role in treatment decision in colorectal cancer patients? Participants already be undergoing for pet ct as part of their follow up routine and will be followed up for 5 years.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Rectal Cancer (Stage III) Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases Rectal Neoplasms

Sex eligibility

All sexes

Study type

Observational

About this study

The importance of pet ct in follow up od CRC patients and see OS.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients with colorectal cancer recieved treatment

Exclusion criteria

pregnent women

Treatment and study plan

Primary outcomes

Diagnostic value of pet ct in colorectal cancer

Time frame: 2 years

Cross sectional

Study contacts

Contact information is provided by the study sponsor or research team.

Waleed Ahmed Diab, Professor

CONTACT

[email protected]

+20 100 4242213 ext. 01006414845

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start: 2026
Primary completion: 2030
Study completion: 2031
First posted: Apr 17, 2026
Registry last updated: Apr 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting